TWST

#1561
Twist Bioscience Corporation Common Stock
57.41 USD
+13.95%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
57.41
57.41
Rango anual
23.30
57.88
Cambio diario
+13.95%
Variación mensual
+31.76%
Variación en los últimos 6 meses
+84.90%
Cambio anual
+43.70%
Cierres anteriores
50.38
Abrir
57.41
Bid
Ask
Mínimo
57.41
High
57.41
Volumen
91
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 202020212022202320242025

Twist Bioscience Corporation

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.

Noticias